Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Banque Nationale de Belgique | BNB | May 13, 2024 | 475.00 | +3.71 |
Barco NV | BAR | May 13, 2024 | 13.51 | -0.30 |
Basilix | BAS | May 13, 2024 | 13.50 | 0.00 |
Beaulieu Av Certificates | BEAB | May 13, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | May 13, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | May 13, 2024 | 3 980.58 | -0.82 |
Belreca - Belgian Resources and Capital Company | BELR | May 13, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | May 13, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | May 13, 2024 | 0.87 | -2.25 |
Biocartis Group NV | BCART | May 13, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | May 13, 2024 | 0.01 | +7.25 |
Biotalys | BTLS | May 13, 2024 | 2.97 | -1.66 |
Boeing | BOEI | May 13, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 13, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 13, 2024 | 3.46 | -0.72 |
Brederode S.A. | BREB | May 13, 2024 | 113.00 | -1.40 |
Campine nv | CAMB | May 13, 2024 | 76.00 | +1.33 |
Candela Invest | CAND | May 13, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 13, 2024 | 14.54 | +1.11 |
Celyad Oncology SA | CYAD | May 13, 2024 | 0.31 | -0.32 |
Cenergy Holdings | CENER | May 13, 2024 | 8.30 | -1.54 |
Chevron | CHTEX | May 13, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 13, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 13, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 13, 2024 | 60.20 | -9.06 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 13, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 13, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 13, 2024 | 43.26 | +1.31 |
Compagnie du Bois Sauvage S.A. | COMB | May 13, 2024 | 262.00 | +0.77 |
Compagnie d`Entreprises CFE SA | CFEB | May 13, 2024 | 7.85 | +1.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.